Cellosaurus logo
expasy logo

Cellosaurus NCC-MFS5-C1 (CVCL_B5YX)

[Text version]
Cell line name NCC-MFS5-C1
Accession CVCL_B5YX
Resource Identification Initiative To cite this cell line use: NCC-MFS5-C1 (RRID:CVCL_B5YX)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
Doubling time: 91.7 hours (PubMed=35053323).
Omics: Phenotyping; Drug screening.
Omics: Variations; SNP array analysis.
Derived from site: In situ; Right elbow, hypodermis; UBERON=UBERON_0001461+UBERON_0002072.
Sequence variations
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 60Y
Category Cancer cell line
STR profile Source(s): PubMed=35053323

Markers:
AmelogeninX,Y
CSF1PO11
D5S81811
D7S82011,12
D13S31711
D16S5399
D21S1130,32
TH018,9
TPOX8
vWA15,18

Run an STR similarity search on this cell line
Web pages Provider; BizCom; -; https://en.cellline.jp/product/ncc-mfs5-c1/
Publications

PubMed=35053323; DOI=10.3390/cells11020207; PMCID=PMC8773631
Ryuto Tsuchiya, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono, Taro Akiyama, Jun Sugaya, Eisuke Kobayashi, Naoki Kojima, Akihiko Yoshida, Seiji Ohtori ...Show all 13 authors... , Akira Kawai, Tadashi Kondo; Show fewer authors
Establishment and characterization of NCC-MFS5-C1: a novel patient-derived cell line of myxofibrosarcoma.
Cells 11:207.1-207.13(2022)

Cross-references
Encyclopedic resources Wikidata; Q112129415
Entry history
Entry creation17-Mar-2022
Last entry update10-Apr-2025
Version number8